フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Karolinska Development’s portfolio company AnaCardio raises SEK 205 million and reports positive Phase 1b data of AC01 STOCKHOLM, SWEDEN January...
Karolinska Development’s portfolio company Umecrine Cognition raises MSEK 23.8 to continue clinical development of golexanolone STOCKHOLM, SWEDEN...
Karolinska Development’s Board of Directors appoints Ben Toogood as new Chairman STOCKHOLM, SWEDEN – December 18, 2024. Karolinska Development AB...
Karolinska Development’s Chairman of the Board resigns at his own request STOCKHOLM, SWEDEN – December 11, 2024. Karolinska Development AB (Nasdaq...
Karolinska Development divests 4,6 million shares in portfolio company OssDsign STOCKHOLM, SWEDEN, December 10, 2024. Karolinska Development AB...
Karolinska Development's portfolio company Modus Therapeutics initiates a phase 2 study with sevuparin for treatment of chronic kidney...
Karolinska Development implements organizational changes for more efficient portfolio management STOCKHOLM, SWEDEN – December 2, 2024. Karolinska...
Karolinska Development's portfolio company Modus Therapeutics secures bridge financing STOCKHOLM, SWEDEN November 19, 2024. Karolinska...
Karolinska Development’s portfolio company Umecrine Cognition presents positive interim data from Phase 1b/2a clinical study STOCKHOLM, SWEDEN –...
Karolinska Development's portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO STOCKHOLM, Sweden, 15 November 2024...
Interim Report - January-September 2024 STOCKHOLM – 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its...
Karolinska Development’s Extraordinary General Meeting 2024 STOCKHOLM, SWEDEN – November 13, 2024. Karolinska Development AB (publ) (“Karolinska...
Karolinska Development’s portfolio company BOOST Pharma successfully completes pre-IND meeting with FDA and receives second tranche of investment...
Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine STOCKHOLM...
Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約